SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001235010-18-000013
Filing Date
2018-08-09
Accepted
2018-08-09 07:52:47
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnta2q201810-q.htm 10-Q 1508979
2 EXHIBIT 10.1 mnta2q201810-qex101.htm EX-10.1 210442
3 EXHIBIT 10.2 mnta2q201810-qex102.htm EX-10.2 61135
4 EXHIBIT 31.1 mnta2q201810-qex311.htm EX-31.1 12315
5 EXHIBIT 32.1 mnta2q201810-qex321.htm EX-32.1 5996
  Complete submission text file 0001235010-18-000013.txt   8151637

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnta-20180630.xml EX-101.INS 2230502
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20180630.xsd EX-101.SCH 45986
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20180630_cal.xml EX-101.CAL 76654
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20180630_def.xml EX-101.DEF 227179
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnta-20180630_lab.xml EX-101.LAB 503230
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20180630_pre.xml EX-101.PRE 317403
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 181003454
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences